Prof. Onno Kranenburg

Prof. Onno Kranenburg

Professor of Surgical and Translational Tumor Biology, Cancer Center UMC Utrecht

Onno Kranenburg is Professor Translational Tumor Biology at the University Medical Center Utrecht (UMCU) and heads the Lab Translational Oncology.

He is also a member of the daily board of the focus area Cancer at the UMCU, coordinator of the PhD education program Clinical and Translational Oncology, and chair of the Utrecht Platform for Organoid Technology (U-PORT).

U-PORT supports the application and further development of organoid technology. Organoids provide excellent model systems for studying all the hallmarks of cancer, including cancer metastasis.

Using colorectal cancer organoids, Kranenburg studies multiple aspects of CRC metastasis, including mechanisms of organ-specific dissemination, survival and outgrowth.

New insights in CRC metastasis biology are used to develop novel diagnostic tools and treatment strategies. These are tested in organoid-based mouse models and, ultimately, in clinical studies.

 

ABSTRACT

Title: Organoid-based models for metastatic Colorectal Cancer with high microsatellite instability 

Summary: Colorectal Cancers (CRC) with a deficient mismatch repair system (dMMR) are characterized by a high level of microsatellite instability (MSI-H) and a hyper-mutated genome. MSI-H is associated with a relatively good prognosis in primary CRC, but with poor prognosis in metastatic CRC (mCRC).

The immunogenic nature of MSI-H mCRC tumors underlies their unique responsiveness to immune-checkpoint inhibitors (ICIs), but response rates are highly variable. Model systems for further pre-clinical optimization of the treatment of MSI-H mCRC are currently lacking.

We describe the establishment of organoids from MSI-H mCRC tumors and organoid-initiated metastasis models, using immune-deficient and Human Immune System (HIS) mice.

The results demonstrate that organoids from MSI-H mCRC can be used for building spontaneous metastasis models in mice involving all relevant distant sites, and in the context of a human immune system. This allows for evaluation of ICI therapies and for further improving ICI-based therapeutic strategies.

IACR Charity Funding

The IACR is a charity which needs your help to support early-stage oncology scientific researchers

What's On? IACR 2023 Agenda

Download the initial draft of the IACR BioMedical agenda for our 59th Annual Conference.

Registration/ Membership for IACR 2023

Registration for the 59th Annual Conference in the Radisson Blu hotel, Athlone is Now Open.

EACR Membership is Included

The IACR is an affiliated national society and its members benefit from full membership of the EACR.

Late Breaking Abstracts in Now OPEN!

Biomedical Session Abstracts

Deadline: Midnight, Friday, 20th January 2023

Please note:
- Patrick Johnston Lay submission category is now closed
- Late Breaking Abstracts submitted to the Biomedical Sessions will be considered for Display Poster Presentation. 

Social Nursing and Allied Health (SNAH) Abstracts

Deadline: Midnight, Monday, 9th January 2023

SNAH abstract submissions will remain open until Monday 9th January.

Any questions?
Please contact Sinead on: sinead@sineadcassidy.com

Contact Us

7 + 12 =

Contact Us
Irish Association for Cancer Research
9A Coolkill, Sandyford, Dublin 18

T: +353 (0)1 295 8859
E: info@iacr.ie

Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations.

Registered Charity Number (RCN): 20030117

Design by patterns.ie
© 2022